During the past decade, Hopital de l'archet conducted 197 clinical trials. In the 10-year time frame, 197 clinical trials started and 79 clinical trials were completed, i.e. on average, 40.1% percent of trials that started reached the finish line to date. In the past 5 years, 85 clinical trials started and 56 clinical trials were completed. i.e. 65.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hopital de l'archet" #1 sponsor was "Groupe Francophone des Myelodysplasies" with 22 trials, followed by "Centre Hospitalier Universitaire de Nice" with 18 trials sponsored, "Eli Lilly and Company" with 12 trials sponsored, "Janssen Research & Development, LLC" with 12 trials sponsored and "Pfizer" with 12 trials sponsored. Other sponsors include 274 different institutions and companies that sponsored additional 134 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital de l'archet" #1 collaborator was "Celgene" with 5 trials as a collaborator, "Celgene Corporation" with 5 trials as a collaborator, "Merck Sharp & Dohme LLC" with 5 trials as a collaborator, "Gilead Sciences" with 4 trials as a collaborator and "Incyte Corporation" with 4 trials as a collaborator. Other collaborators include 107 different institutions and companies that were collaborators in the rest 89 trials.

According to Clinical.Site data, the most researched conditions in "Hopital de l'archet" are "Ulcerative Colitis" (24 trials), "Myelodysplastic Syndromes" (23 trials), "Psoriasis" (15 trials), "Acute Myeloid Leukemia" (12 trials) and "Crohn Disease" (12 trials). Many other conditions were trialed in "Hopital de l'archet" in a lesser frequency.

Most popular intervention types in "Hopital de l'archet" are "Drug" (255 trials), "Other" (56 trials), "Procedure" (31 trials), "Biological" (25 trials) and "Device" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (73 trials), "Azacitidine" (9 trials), "Guselkumab" (6 trials), "fluorouracil" (6 trials) and "leucovorin calcium" (6 trials). Other intervention names were less common.

The vast majority of trials in "Hopital de l'archet" are 337 trials for "All" genders, 14 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are 107 active trials in "Hopital de l'archet". 3 are not yet recruiting, 63 are recruiting, 40 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 167 completed trials in Hopital de l'archet, undefined suspended trials, and 36 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital de l'archet, 16 "Phase 1" clinical trials were conducted, 103 "Phase 2" clinical trials and 149 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 16 trials, and there were also 48 trials that are defined as “Not Applicable".